Stevens-Johnson syndrome (SJS) is a severe form of erythema multiforme that primarily affects skin and mucous membranes. In Malawi, manifestations of SJS may become more common in human immunodeficiency virus-infected patients receiving nevirapine-based antiretroviral therapy (ART) because the CD4 cell threshold for starting ART has increased from 250 to 350 cells/mL. We describe a patient with severe ocular complications from SJS that developed soon after initiation of nevirapine-based ART and cotrimoxazole preventive treatment, which led to blindness. We draw attention to preventive measures that can potentially reduce permanent ocular damage from SJS.© 2013 by The American Society of Tropical.
CITATION STYLE
Schwering, M. S., Kayange, P., Van Oosterhout, J. J., & Spitzer, M. S. (2013). Case report: Severe eye complications from stevens-johnson syndrome in a human immunodeficiency virus-infected patient in malawi. American Journal of Tropical Medicine and Hygiene, 89(1), 162–164. https://doi.org/10.4269/ajtmh.12-0761
Mendeley helps you to discover research relevant for your work.